Galen Growthhttps://www.galengrowth.com/Digital health intelligence and analysisBuild, Buy or Partner: How to Spend a 2027 Digital Health Budgethttps://www.galengrowth.com/build-buy-or-partner-how-to-spend-a-2027-digital-health-budget/https://www.galengrowth.com/build-buy-or-partner-how-to-spend-a-2027-digital-health-budget/Tue, 22 Sep 2026 05:31:41 GMTThe AI label now carries a 16% funding discount and acquired ventures average 10.7 years old. How to choose between building, buying and partnering in 2027.The Ten-Week Window: A Q4 Planning Guide for Your 2027 Digital Health Budgethttps://www.galengrowth.com/ten-week-window-2027-digital-health-budget/https://www.galengrowth.com/ten-week-window-2027-digital-health-budget/Tue, 15 Sep 2026 04:04:24 GMTMost 2027 innovation budgets are written in the next ten weeks. Part one of Galen Growth’s Q4 planning guide: the market you are budgeting intoRead-Only Is the Whole Story: OpenAI's Epic Integration and the Clinical Reasoning Layer, September 2026https://www.galengrowth.com/openai-epic-integration-clinical-reasoning-layer-2026/https://www.galengrowth.com/openai-epic-integration-clinical-reasoning-layer-2026/Tue, 08 Sep 2026 07:23:00 GMTOpenAI's Epic integration is read-only — no notes, no orders, no codes. Epic, Abridge and Ambience shipped chart reasoning first, and $1.32B backed them in 2025.SEO key phrase: OpenAI Epic integrationPharma's Digital Health Partnerships: The Asset Investors Don't Seehttps://www.galengrowth.com/pharma-digital-health-partnerships-2026/https://www.galengrowth.com/pharma-digital-health-partnerships-2026/Tue, 01 Sep 2026 07:10:41 GMTPharma holds 1,707 Digital Health partnerships across 13 portfolios — a measurable asset investors ignore. Novartis converts 31% to evidence grade; Bayer 18%.The Operating System Around the Drug: Patient Support Programmes in 2026https://www.galengrowth.com/pharma-patient-support-programmes-digital-health/https://www.galengrowth.com/pharma-patient-support-programmes-digital-health/Tue, 25 Aug 2026 09:17:51 GMT281 ventures, US$5.9bn raised, 628 pharma partnerships: patient support programmes are becoming treatment infrastructure. Galen Growth, 2026.Why Hinge Health Paid $105 Million for a Company Worth Just $8 Million in Revenuehttps://www.galengrowth.com/hinge-health-cylinder-health-acquisition-digital-health-platforms/https://www.galengrowth.com/hinge-health-cylinder-health-acquisition-digital-health-platforms/Tue, 18 Aug 2026 05:17:15 GMTHinge Health paid $105M for Cylinder Health, but the deal adds just $7–8M in 2026 revenue — Galen Growth's analysis of the platform-building logic behind it.Digital Health Funding 2026: Ventures with Strong Clinical Evidence Raise 3.5x Morehttps://www.galengrowth.com/digital-health-funding-clinical-evidence-2026/https://www.galengrowth.com/digital-health-funding-clinical-evidence-2026/Tue, 11 Aug 2026 03:50:59 GMTVentures with strong clinical evidence raised 3.5x more in 2026 YTD ($112.9M vs $24.3M/round) — Galen Growth digital health funding analysis.Digital Health Investment Trends in H1 2026: 5 New Rules of Healthcare Innovation Venture Capitalhttps://www.galengrowth.com/h1-2026-digital-health-investment-trends/https://www.galengrowth.com/h1-2026-digital-health-investment-trends/Tue, 04 Aug 2026 02:35:31 GMTDeal volume fell 63% in H1 2026, yet capital held at $16.6B. Galen Growth's H1 2026 Key Trends analysis reveals the 5 new rules reshaping digital health VC.H1 2026 Healthcare Trends: Health Systems Are Buying Infrastructure, Not Appshttps://www.galengrowth.com/healthcare-buying-infrastructure-not-apps-2026/https://www.galengrowth.com/healthcare-buying-infrastructure-not-apps-2026/Tue, 28 Jul 2026 05:27:06 GMTHealth-system partnerships with infrastructure ventures rose to 22.8% in H1 2026 from 18.8% in 2022, Galen Growth's H1 2026 data show.The Return of the Strategic Buyer: M&A Captured 98% of Digital Health Exits in H1 2026https://www.galengrowth.com/h1-2026-digital-health-exits-strategic-buyers/https://www.galengrowth.com/h1-2026-digital-health-exits-strategic-buyers/Mon, 20 Jul 2026 23:59:00 GMTM&A captured 97.6% of digital health exits in H1 2026 as IPOs fell to one listing. Galen Growth's H1 2026 exit analysis, powered by HealthTech Alpha.H1 2026 Digital Health Trends: Why Partnerships Matter More Than Fundinghttps://www.galengrowth.com/h1-2026-digital-health-partnerships-vs-funding/https://www.galengrowth.com/h1-2026-digital-health-partnerships-vs-funding/Tue, 14 Jul 2026 00:20:00 GMTPartnerships fell 20% vs a 37% funding deal decline in H1 2026. Galen Growth’s definitive read on why partnerships now signal digital health demand.Global funding held broadly steady at $22.6B — H1 2026 data shows capital concentrating in fewer, larger, more scrutinised bets.https://www.galengrowth.com/digital-health-h1-2026-maturity-era/https://www.galengrowth.com/digital-health-h1-2026-maturity-era/Tue, 07 Jul 2026 04:27:33 GMTGlobal digital health funding held steady at $22.6B in H1 2026, but deal count fell 38% to 608. Galen Growth's definitive analysis of the maturity era.Digital Health Exits in 2026: M&A Dominance, Longer Hold Periods, and Strategic Consolidationhttps://www.galengrowth.com/digital-health-exits-2026-ma-dominance/https://www.galengrowth.com/digital-health-exits-2026-ma-dominance/Tue, 30 Jun 2026 04:27:41 GMT95% of 2025–2026 digital health exits were M&A. Galen Growth analysis of exit routes, hold periods, and capital concentration for 2026.The Q3 Intelligence Window: Why Alpha Briefs Matter Before the Q4 Pushhttps://www.galengrowth.com/alpha-brief-q3-q4-healthcare-innovation-intelligence-2026/https://www.galengrowth.com/alpha-brief-q3-q4-healthcare-innovation-intelligence-2026/Fri, 26 Jun 2026 05:10:00 GMTQ3 offers a 12-week window to turn healthcare innovation noise into Q4-ready decisions with Galen Growth Alpha Briefs.The €5 billion question: is Europe finally building strategic capital — or still thinking too small?https://www.galengrowth.com/scaleup-europe-fund-digital-health-2026/https://www.galengrowth.com/scaleup-europe-fund-digital-health-2026/Mon, 15 Jun 2026 22:25:00 GMTScaleup Europe Fund targets €5bn, but HealthTech Alpha data shows Europe’s real gap is Series C–E growth capitalBig Tech is no longer experimenting at the edges of healthcare. Microsoft, Amazon, Google, Apple, NVIDIA and Meta are becoming part of healthcare’s infrastructure, AI, data, consumer access and venture partnership layer.https://www.galengrowth.com/big-tech-role-in-healthcare/https://www.galengrowth.com/big-tech-role-in-healthcare/Mon, 15 Jun 2026 01:31:42 GMTBig Tech is becoming part of the operating system of modern healthcare. From AI and cloud infrastructure to wearables, pharmacy, clinical workflow and digital health partnerships, companies such as Microsoft, Amazon, Google, Apple and NVIDIA are reshaping how healthcare is delivered, analyzed and accessed.The $2.1bn wager on machine-made medicine: why Isomorphic Labs may redraw the economics of drug discoveryhttps://www.galengrowth.com/isomorphic-labs-2-1bn-series-b-ai-drug-discovery/https://www.galengrowth.com/isomorphic-labs-2-1bn-series-b-ai-drug-discovery/Tue, 09 Jun 2026 02:58:23 GMTIsomorphic Labs' $2.1B Series B signals a major shift in AI drug discovery. Explore what the funding means for pharma, investors, AI biology and the future of medicine.The Investable Core: Why Investors Are Backing Health Management Solutions in 2026https://www.galengrowth.com/investor-thesis-health-management-solutions-funding-2026/https://www.galengrowth.com/investor-thesis-health-management-solutions-funding-2026/Tue, 02 Jun 2026 04:21:55 GMTRoche’s $1.05bn acquisition of PathAI raises new questions around AI infrastructure neutrality, companion diagnostics and vendor governanceRoche acquires PathAI: pharma partners face a vendor-risk problemhttps://www.galengrowth.com/roche-pathai-vendor-governance-risk/https://www.galengrowth.com/roche-pathai-vendor-governance-risk/Tue, 26 May 2026 07:32:07 GMTRoche’s $1.05bn acquisition of PathAI raises new questions around AI infrastructure neutrality, companion diagnostics and vendor governanceAI in U.S. Healthcare Operations: Why Health Management Solutions Became the New Infrastructure Layerhttps://www.galengrowth.com/from-crisis-to-catalyst-us-health-management-solutions-2026/https://www.galengrowth.com/from-crisis-to-catalyst-us-health-management-solutions-2026/Tue, 12 May 2026 05:50:38 GMTU.S. Health Management Solutions funding reached $4.5B in 2025, with 83% of Q1 2026 funding going to AI-powered ventures. See why healthcare operations, workflow automation, and clinical data infrastructure are becoming the new AI infrastructure layer.The Execution Decade: Why Clinical Trials Are Pharma’s 2026 R&D Bottleneckhttps://www.galengrowth.com/the-execution-decade-digital-health-pharma-rd-2026/https://www.galengrowth.com/the-execution-decade-digital-health-pharma-rd-2026/Thu, 07 May 2026 13:36:14 GMTDigital health raised $25.7bn in venture equity in 2025, but Clinical Trials — the layer fixing pharma’s productivity problem — took just $350m. The misallocation to correct in 2026.The Administration Problem: How $5.6B Rewired Health Management Solutions in 2025https://www.galengrowth.com/health-management-solutions-2025-ai-reset/https://www.galengrowth.com/health-management-solutions-2025-ai-reset/Tue, 05 May 2026 05:19:32 GMTHealth Management Solutions captured $5.6B in 2025 venture funding — 83% to AI. Galen Growth's analysis of the global HMS reset.Scale, Speed, and State Power: Asia Pacific’s Digital Health Funding Market in Q1 2026https://www.galengrowth.com/asia-pacific-digital-health-funding-q1-2026-analysis/https://www.galengrowth.com/asia-pacific-digital-health-funding-q1-2026-analysis/Tue, 21 Apr 2026 07:23:41 GMTAsia Pacific digital health funding hits $2.65B in strategic deals vs $244M VC in Q1 2026, revealing a bifurcated, infrastructure-driven market.Proof, Precision, and Power: Europe’s Digital Health Funding Market in Q1 2026https://www.galengrowth.com/europe-digital-health-funding-q1-2026-analysis/https://www.galengrowth.com/europe-digital-health-funding-q1-2026-analysis/Thu, 16 Apr 2026 09:24:37 GMTEurope digital health funding hits $1.2B in Q1 2026 as late-stage funding, provider partnerships, and M&A signal market maturity.The American Powerplay: U.S. Digital Health Funding in Q1 2026https://www.galengrowth.com/the-american-powerplay-u-s-digital-health-funding-in-q1-2026/https://www.galengrowth.com/the-american-powerplay-u-s-digital-health-funding-in-q1-2026/Tue, 14 Apr 2026 05:48:11 GMTU.S. digital health funding captured 76% of global funding in Q1 2026. Explore VC trends, AI dominance, partnerships, and exits shaping the market.Global Digital Health Ecosystem Q1 2026 Performance Reviewhttps://www.galengrowth.com/digital-health-q1-2026-trends/https://www.galengrowth.com/digital-health-q1-2026-trends/Wed, 08 Apr 2026 07:30:50 GMTExplore Q1 2026 digital health trends: $7.1B funding, rising M&A, and the shift toward clinical, scalable solutions.Digital health funding in Clinical Trials: Why Execution, Not Discovery, is Pharma’s Next Existential Bottleneckhttps://www.galengrowth.com/clinical-trial-execution-pharma-bottleneck/https://www.galengrowth.com/clinical-trial-execution-pharma-bottleneck/Tue, 31 Mar 2026 04:36:04 GMTClinical trial execution, not discovery, is pharma’s real bottleneck as AI, DCTs, and workflow innovation reshape the market.Next Generation Power Players: HealthTech 250 Reveals 50 Emerging Digital Health Startups in Top Clustershttps://www.galengrowth.com/healthtech-250-digital-health-startups-2026/https://www.galengrowth.com/healthtech-250-digital-health-startups-2026/Tue, 24 Mar 2026 08:03:47 GMTExplore the 2026 HealthTech 250—top digital health startups across key clusters driving $29.7B in funding and evidence-backed innovation.The Signal Beneath the Noise: What the 2026 HT250 Tells Investors About Where Digital Health Is Actually Headinghttps://www.galengrowth.com/ht250-2026-digital-health-investor-signals/https://www.galengrowth.com/ht250-2026-digital-health-investor-signals/Tue, 17 Mar 2026 08:13:08 GMTExplore what the 2026 HT250 reveals about digital health investment trends, AI adoption, clinical validation, and where investors should look across the US, Europe, and APAC.Coming of Age in Basel: Digital Health Acts its Age at health.tech 2026https://www.galengrowth.com/coming-of-age-in-basel-digital-health-acts-its-age-at-health-tech-2026/https://www.galengrowth.com/coming-of-age-in-basel-digital-health-acts-its-age-at-health-tech-2026/Tue, 10 Mar 2026 04:50:39 GMThealth.tech 2026 in Basel showed digital health entering its implementation era, from AI deployment and governance to prevention systems and digital clinical trials.Beyond the Hype: Why the HealthTech 250 APAC Cohort Mattershttps://www.galengrowth.com/healthtech-250-apac-cohort/https://www.galengrowth.com/healthtech-250-apac-cohort/Thu, 05 Mar 2026 07:39:07 GMTThe HealthTech 250 APAC cohort highlights 50 early-stage digital health startups across Asia Pacific backed by funding momentum, partnerships, and real ecosystem traction.Rewiring Healthcare with the HealthTech 250 U.S. Cohorthttps://www.galengrowth.com/healthtech-250-us-cohort-2026/https://www.galengrowth.com/healthtech-250-us-cohort-2026/Thu, 05 Mar 2026 07:28:33 GMTDiscover the 2026 HealthTech 250 U.S. cohort — 75 early-stage digital health startups transforming healthcare operations, oncology innovation, and therapeutic-specific care.Beyond the Hype: The HealthTech 250 Europe 2026 Cohort Highlights the Digital Health Startups Driving Real Innovationhttps://www.galengrowth.com/healthtech-250-europe-2026-digital-health-startups/https://www.galengrowth.com/healthtech-250-europe-2026-digital-health-startups/Tue, 03 Mar 2026 10:38:56 GMTExplore the HealthTech 250 Europe 2026 cohort: 50 early-stage digital health startups leading in AI, oncology, diagnostics, and evidence-backed innovation.Carbon Health: How a US$2.8bn Digital Health unicorn discovered clinics don’t scale like softwarehttps://www.galengrowth.com/carbon-health-bankruptcy/https://www.galengrowth.com/carbon-health-bankruptcy/Thu, 26 Feb 2026 07:17:11 GMTA $2.8bn digital health unicorn enters Chapter 11—revealing why clinics don’t scale like software and what investors should learn.Vertical AI in Healthcare: Vertical AI Beats Horizontal in the Agentic AI Era — Why Specialist Intelligence Winshttps://www.galengrowth.com/vertical-vs-horizontal-agentic-ai-digital-health/https://www.galengrowth.com/vertical-vs-horizontal-agentic-ai-digital-health/Tue, 24 Feb 2026 04:44:59 GMTIn the agentic AI era, defensibility shifts from foundation models to vertical data moats. In healthcare, specialist Digital Health Intelligence platforms outperform horizontal systems by providing domain-specific taxonomy, entity resolution, auditability, and governance required for decision-grade enterprise deployment.Digital health exits: fewer fireworks, firmer foundationshttps://www.galengrowth.com/digital-health-exits-2025-ma-trends/https://www.galengrowth.com/digital-health-exits-2025-ma-trends/Tue, 17 Feb 2026 09:31:45 GMTDigital health exits reached $13.9bn in 2025, marking a 10.6% year-on-year increase and signaling a shift from volatility to a more disciplined, M&A-driven baseline. Venture-to-venture acquisitions now dominate consolidation, while capital increasingly flows to infrastructure-heavy segments like research solutions and health management. As IPOs remain selective, 2026 is set to further entrench strategic, integration-led exits over valuation-driven outcomes.The Galen Growth HealthTech 250, one year on: separating signal from noise in digital health ventureshttps://www.galengrowth.com/healthtech-250-one-year-on-digital-health-performance-2025/https://www.galengrowth.com/healthtech-250-one-year-on-digital-health-performance-2025/Thu, 12 Feb 2026 07:19:06 GMTOne year after selection, the 2025 HealthTech 250 demonstrates exceptional resilience, raising $1.6B, securing 1,001 partnerships, and maintaining a 96% survival rate. In a selective capital market, evidence, workflow integration, and measurable ROI—not hype—are defining digital health’s real winners.Shaping the Future of Digital Health: Galen Growth’s Conference Line-Up for 2026https://www.galengrowth.com/shaping-future-digital-health-conference-lineup-2026/https://www.galengrowth.com/shaping-future-digital-health-conference-lineup-2026/Tue, 10 Feb 2026 09:26:21 GMTSee where to meet Galen Growth in 2026—from JPM to HLTH Europe and HLTH USA—and what evidence-led signals we track using HealthTech Alpha.2025 Was the Year Europe Got Paid. 2026 Is the Year Europe Must Prove It Was Worth It.https://www.galengrowth.com/europe-digital-health-funding-2026-test/https://www.galengrowth.com/europe-digital-health-funding-2026-test/Tue, 03 Feb 2026 02:23:00 GMTEurope led global digital health funding growth in 2025, driven by U.S. capital. In 2026, exits not rounds will determine success.Sword Health’s European Roots Fuel a Global Power Playhttps://www.galengrowth.com/in-the-battle-for-digital-health-supremacy-sword-healths-european-roots-fuel-a-global-power-play/https://www.galengrowth.com/in-the-battle-for-digital-health-supremacy-sword-healths-european-roots-fuel-a-global-power-play/Thu, 29 Jan 2026 11:05:32 GMTSword Health’s $285M Kaia Health acquisition signals digital MSK consolidation, blending sensors, AI vision, and Germany’s DiGA moat.U.S. Digital Health Funding 2025: The Year the Health System Took the Driver’s Seathttps://www.galengrowth.com/provider-led-digital-health/https://www.galengrowth.com/provider-led-digital-health/Thu, 29 Jan 2026 08:40:26 GMTU.S. digital health funding hit $19.2B in 2025—but power shifted to health systems. Learn why workflow ROI, EHR integration, and provider adoption now define what scales.Asia Pacific Digital Health 2025: Australia Leads, Women’s Health Surges, and a Cash Crunch Loomshttps://www.galengrowth.com/apac-digital-health-2025-funding-shifts-and-risks/https://www.galengrowth.com/apac-digital-health-2025-funding-shifts-and-risks/Mon, 26 Jan 2026 10:39:18 GMTAPAC digital health funding rose 14% in 2025. Australia leads, Women’s Health surges, and a growth-stage cash crunch emerges.Digital Health Funding 2025: the year capital stopped believing the hypehttps://www.galengrowth.com/digital-health-funding-2025-the-year-capital-stopped-believing-the-hype/https://www.galengrowth.com/digital-health-funding-2025-the-year-capital-stopped-believing-the-hype/Tue, 20 Jan 2026 04:42:38 GMTDigital health funding hit USD 28.8B in 2025—but concentrated into fewer winners. Europe grew fastest, and buyers demanded ROI, evidence, and interoperability.Digital Health 2026: Ten Predictions as the Industry Shifts From Hype to Hardwiringhttps://www.galengrowth.com/digital-health-2026-predictions-hype-to-hardwiring/https://www.galengrowth.com/digital-health-2026-predictions-hype-to-hardwiring/Tue, 13 Jan 2026 08:48:25 GMTIn 2026, digital health shifts from experimentation to infrastructure. Ten predictions on clinical-grade data, operational AI, interoperability, regulation, and capital.Digital Health Funding in 2025: From Hype to Hard Resultshttps://www.galengrowth.com/digital-health-funding-2025/https://www.galengrowth.com/digital-health-funding-2025/Tue, 06 Jan 2026 05:48:39 GMTIn 2025, digital health funding reset around discipline, outcomes, and real-world impact—creating a stronger foundation for sustainable growth.In Uncertain Times, Innovation Lights the Way: Year-End Reflectionshttps://www.galengrowth.com/healthcare-innovation-uncertain-times-2025/https://www.galengrowth.com/healthcare-innovation-uncertain-times-2025/Tue, 30 Dec 2025 00:02:00 GMTA year-end reflection on how healthcare innovation, AI, and digital health matured in 2025 despite geopolitical and economic uncertainty.The Twelve Days of Digital Health (2025 Edition)https://www.galengrowth.com/twelve-days-digital-health-trends-2025/https://www.galengrowth.com/twelve-days-digital-health-trends-2025/Tue, 23 Dec 2025 00:01:00 GMTThis article provides a structured, evidence-led overview of digital health trends in 2025, covering pharma, payers, providers, regulators, and health technology vendors globally.Who has the Golden Checkbook: Inside the 50 Core Investors Re-Wiring Global Digital Health (2025)https://www.galengrowth.com/50-core-digital-health-investors-2025/https://www.galengrowth.com/50-core-digital-health-investors-2025/Mon, 15 Dec 2025 16:08:04 GMTThe HT50 Core Investors 2025 report reveals the 50 investors shaping global digital health—across stages, regions and themes. Drawing on HealthTech Alpha data, it shows how capital, evidence and partnerships are redefining who really moves the market.From Vision to Global Impact: Galen Growth Turns 10https://www.galengrowth.com/galen-growth-10-years-digital-health-intelligence/https://www.galengrowth.com/galen-growth-10-years-digital-health-intelligence/Tue, 09 Dec 2025 08:36:06 GMTCelebrating 10 years of Galen Growth, the Singapore-born global leader in Digital Health Intelligence powering evidence-based decisions across healthcare.Who is really winning pharma’s digital health innovation race in 2025?https://www.galengrowth.com/pharma-digital-health-innovation-index-2025/https://www.galengrowth.com/pharma-digital-health-innovation-index-2025/Tue, 02 Dec 2025 08:10:45 GMTGalen Growth’s 2025 Pharmaceutical Digital Health Innovation Index ranks the 25 most active global pharma companies on how effectively they embed digital health across strategy, execution and venture portfolios. The report reveals which firms are truly leading – from Proactive quadrant powerhouses like Novartis and AstraZeneca to R&D specialists and patient-first pioneers – using only independent, evidence-led data from HealthTech Alpha.